Search results for "vascular endothelial growth factor"

showing 10 items of 320 documents

Large platelets but not putative endothelial progenitor cells are associated with low strut coverage after drug-eluting stent implantation

2015

Objectives This study assessed whether different subsets of circulating endothelial and putative endothelial progenitor cells (CEC and EPC) correlate with stent strut coverage (SSC) using second generation optical coherence tomography (OCT). Background Due to the lack of imaging modalities with a resolution down to the magnitude of a few cells, the influence of EPC on endothelialisation of drug-eluting stents has not been assessed in patients. Methods In 37 patients, SSC of everolimus-eluting stents was assessed by OCT 5-7months after stent implantation. Different subsets of EPC (CD34(+)KDR(+), CD34(+)KDR(+)CD45(dim), CD133(+), CD3(+)CD31(+)), CEC (CD31(+)CD45(-)CD146(+)), and CD31(+)CD45(-…

Blood PlateletsMaleCD31medicine.medical_specialtymedicine.medical_treatmentCD34UrologyFlow cytometryBlood Vessel Prosthesis ImplantationAntigens CDmedicineHumansPlateletEverolimusProgenitor cellAgedEndothelial Progenitor Cellsmedicine.diagnostic_testbusiness.industryStentDrug-Eluting StentsKinase insert domain receptorMiddle AgedFlow CytometryVascular Endothelial Growth Factor Receptor-2Drug-eluting stentImmunologycardiovascular systemFemaleCardiology and Cardiovascular MedicinebusinessImmunosuppressive AgentsTomography Optical CoherenceInternational Journal of Cardiology
researchProduct

Analysis and comparison of autologous platelet-rich plasma preparation systems used in the treatment of enthesopathies: A preliminary study

2021

Background Autologous platelet-rich plasma (PRP) injection is an alternative but widely accepted method for the treatment of degenerative changes in tendon attachments known as enthesopathies. The PRP is considered a safe source for high concentrations of the growth factors involved in the healing process. Despite initial promising outcomes, many recent studies report conflicting results for this treatment. This may be due to differences in the concentrations of platelets and growth factors in PRPs obtained using different methods. Objectives The aim of this study was to compare PRP preparation systems in terms of morphotic components and selected growth factors to find the most appropriate…

Blood PlateletsMaleVascular Endothelial Growth Factor APlatelet-derived growth factormedicine.medical_treatmentPopulationMedicine (miscellaneous)EnthesopathyGeneral Biochemistry Genetics and Molecular Biologyplatelet-derived growth factorTransforming Growth Factor beta1AndrologyLeukocyte Countchemistry.chemical_compoundEpidermal growth factorgrowth factorsInternal MedicinemedicineHumansPharmacology (medical)PlateleteducationGenetics (clinical)Whole bloodeducation.field_of_studyEpidermal Growth FactorPlatelet-Rich Plasmabusiness.industryGrowth factorVascular endothelial growth factorchemistryPlatelet-rich plasmaReviews and References (medical)businessAdvances in Clinical and Experimental Medicine
researchProduct

Tumorigenic conversion of endothelial cells.

2003

Tumors of endothelial origin develop rarely. Until now, only two angiosarcoma (AS)-derived endothelial cell lines have been be isolated, ISO-HAS and AS-M. Both AS-derived endothelial cell lines presented the typical endothelial characteristics, such as the expression of CD31 and von Willebrand factor, but differed from normal endothelial cells in a nuclear expression of p53, in a delayed angiogenic reaction, and a reduced expression of caveolin. In addition, differences in the expression of cytokines and cell adhesion molecules responsive to proinflammatory stimuli were observed. While AS-M showed an expression pattern similar to that of human umbilical vein endothelial cells (HUVEC), ISO-H…

CD31AdultLipopolysaccharidesTelomerasePathologymedicine.medical_specialtyClinical BiochemistryCaveolin 1Vascular Cell Adhesion Molecule-1BiologyCaveolinsPathology and Forensic Medicinevon Willebrand FactormedicineCell AdhesionHumansMolecular BiologyTelomeraseCells CulturedCell NucleusCell adhesion moleculeReverse Transcriptase Polymerase Chain ReactionGranulocyte-Macrophage Colony-Stimulating FactorTelomereIntercellular Adhesion Molecule-1Cell biologyVascular endothelial growth factor BEndothelial stem cellDNA-Binding ProteinsPlatelet Endothelial Cell Adhesion Molecule-1Vascular endothelial growth factor ACell Transformation NeoplasticVascular endothelial growth factor CCell cultureEndothelium VascularTumor Suppressor Protein p53Experimental and molecular pathology
researchProduct

Angiogenesis-related prognosis in patients with oral squamous cell carcinoma-role of the VEGF +936 C/T polymorphism.

2014

BACKGROUND: The aim of the study was the immunohistological assessment of VEGF-single nucleotide polymorphism (SNP)-related angiogenic activity in oral squamous cell carcinoma (OSCC) in correlation with prognosis. METHODS: Fifty OSCC samples were immunostained with CD31-antibodies. Mean microvessel density (MVD) and staining intensity were determined and associated with clinicopathological/prognostic features as well as with the VEGF +936C/T SNP. RESULTS: A significant higher MVD could be seen for T3 and T4 compared with T1 and T2, N > 0 vs. N0 as well as G3–G4 vs. G1–G2 OSCCs (all: P < 0.05). A higher MVD was also associated with increased and earlier rates of local relapses, more metastas…

CD31AdultMaleVascular Endothelial Growth Factor ACancer Researchmedicine.medical_specialtyPathologyAngiogenesisVEGF receptorsSingle-nucleotide polymorphismBiologyGastroenterologyPolymorphism Single NucleotideDisease-Free SurvivalPathology and Forensic MedicineInternal medicinemedicineSNPHumansAlleleAgedAged 80 and overNeovascularization PathologicSquamous Cell Carcinoma of Head and NeckNeoplasms Second PrimaryMiddle AgedPrognosisImmunohistochemistryStainingSurvival Ratestomatognathic diseasesOtorhinolaryngologyHead and Neck NeoplasmsLymphatic Metastasisbiology.proteinCarcinoma Squamous CellPeriodonticsFemaleMouth NeoplasmsOral SurgeryNeoplasm Recurrence LocalImmunostainingJournal of oral pathologymedicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
researchProduct

Endothelial VEGFR-3 expression in colorectal carcinomas is associated with hematogenous metastasis

2009

Vascular endothelial growth factor receptor 3 (VEGFR-3) is a major inducer of lymphangiogenic signalling and seems to be involved also in angiogenesis. Since both processes are closely linked with tumor metastasis this study investigated the expression of VEGFR-3 in tumor-associated vessels in colorectal carcinomas and evaluated its relevance for lymphogenous and hematogenous metastasis. In a comparative study between microvascular endothelial cells isolated from the tumor (HCTEC) and the corresponding non-neoplastic tissue (HCMEC) from five patients with colorectal cancer VEGFR-3 expression was measured using a specific ELISA. The expression pattern was individually different, with cases s…

CD31Cancer ResearchPathologymedicine.medical_specialtyColonColorectal cancerAngiogenesisFluorescent Antibody TechniqueEnzyme-Linked Immunosorbent AssayMetastasisImmunoenzyme TechniquesmedicineHumansNeoplasm MetastasisLymphatic VesselsNeovascularization PathologicOncogenebusiness.industryCancerGeneral MedicineFlow CytometryPrognosisVascular Endothelial Growth Factor Receptor-3medicine.diseaseCell HypoxiaEndothelial stem cellLymphatic systemOncologyLymphatic Metastasiscardiovascular systemEndothelium VascularEndothelium LymphaticColorectal NeoplasmsbusinessOncology Reports
researchProduct

Searching for the right timing of surgical delay: angiogenesis, vascular endothelial growth factor and perfusion changes in a skin-flap model.

2009

Summary Background The angiogenic potential of vascular endothelial growth factor (VEGF) and its oxygen pressure-dependent regulation suggest a strong connection between this growth factor and the ‘delay phenomenon'. In this study we focused on the chronological changes in VEGF concentration and flap perfusion in order to optimise the duration of surgical delay. Methods The VEGF concentration in skin and underlying muscle was measured in oversized, random-pattern flaps on 38 male Sprague-Dawley rats after 3, 5 or 7 days of surgical delay. Additionally, flaps were raised 5 or 7 days past preconditioning. The effect on flap perfusion was measured using indocyanine green fluoroscopy and the si…

CD31Graft RejectionMalemedicine.medical_specialtyTime FactorsAngiogenesismedicine.medical_treatmentNeovascularization PhysiologicVasodilationEnzyme-Linked Immunosorbent AssayStatistics NonparametricSurgical FlapsNeovascularizationRats Sprague-Dawleychemistry.chemical_compoundRandom AllocationLaser-Doppler FlowmetryMedicineAnimalsProbabilitySkinbusiness.industryVascular Endothelial Growth FactorsGrowth factorMicrocirculationGraft SurvivalSkin TransplantationSurgeryRatsVascular endothelial growth factorDisease Models AnimalchemistryMultivariate AnalysisSurgerymedicine.symptombusinessIndocyanine greenPerfusionBiomarkersJournal of plastic, reconstructiveaesthetic surgery : JPRAS
researchProduct

Uterine glomeruloid hemangioma in a patient without POEMS syndrome.

2011

Cutaneous glomeruloid hemangioma is a hallmark of POEMS syndrome. These patients have elevated serum levels of vascular endothelial growth factor. The authors report an extracutaneous uterine glomeruloid hemangioma in an 82-year-old woman with a history of breast and endometrial carcinomas. Within the lumen of myometrial vessels, a lobular, glomeruloid proliferation of capillary-like CD31 and vascular endothelial growth factor receptor-1-positive endothelial cells was found. The capillary loops were lined by endothelial cells, most of them containing PAS-positive and immunoglobulin-positive eosinophilic hyaline globules (thanatosomes). This vascular proliferation was consistent with a glom…

CD31Pathologymedicine.medical_specialtyEndotheliumAdipose tissuePathology and Forensic MedicineNeoplasms Multiple Primarychemistry.chemical_compoundFatal OutcomemedicineBiomarkers TumorHumansHyalinePOEMS syndromeAged 80 and overbusiness.industrymedicine.diseaseGlomeruloid hemangiomaEndothelial stem cellVascular endothelial growth factormedicine.anatomical_structurechemistryPOEMS SyndromeUterine NeoplasmsSurgeryFemaleEndothelium VascularAnatomybusinessHemangiomaInternational journal of surgical pathology
researchProduct

Paracrine Effects Influenced by Cell Culture Medium and Consequences on Microvessel-Like Structures in Cocultures of Mesenchymal Stem Cells and Outgr…

2011

Mesenchymal stem cells (MSC) from bone marrow and outgrowth endothelial cells (OEC) from peripheral blood are considered as attractive cell types for applications in regenerative medicine aiming to build up complex vascularized tissue-engineered constructs. MSC provide several advantages such as the potential to differentiate to osteoblasts and to support the neovascularization process by release of proangiogenic factors. On the other hand, the neovascularization process can be actively supported by OEC forming perfused vascular structures after co-implantation with other cell types. In this study the formation of angiogenic structures in vitro was investigated in cocultures of MSC and OEC,…

CD31medicine.medical_treatmentCellular differentiationBiomedical EngineeringFluorescent Antibody TechniqueEnzyme-Linked Immunosorbent AssayBioengineeringCD146 AntigenBiologyPolymerase Chain ReactionBiochemistryBiomaterialsParacrine signallingchemistry.chemical_compoundmedicineHumansCells CulturedGrowth factorMesenchymal stem cellEndothelial CellsCell DifferentiationMesenchymal Stem CellsFlow CytometryCoculture TechniquesCulture MediaCell biologyPlatelet Endothelial Cell Adhesion Molecule-1Vascular endothelial growth factorchemistryCell cultureImmunologyCD146Tissue Engineering Part A
researchProduct

In vitro evaluation of biomimetic chitosan-calcium phosphate scaffolds with potential application in bone tissue engineering.

2013

This work reports on the physicochemical properties and in vitro cytotoxicity assessment of chitosan–calcium phosphate (Cs–CP) scaffolds for bone tissue engineering, which were synthesized by a novel biomimetic co-precipitation method. X-ray diffraction (XRD) along with scanning electron microscopy (SEM) analysis confirmed the porous morphology of the scaffolds and the amorphous nature of the inorganic phase with different crystallite sizes and the formation of various forms of calcium phosphate. Compressive mechanical testing revealed that the Young’s modulus of the biomaterials is in the range of human trabecular bone. In vitro tests were performed on the biomaterials for up to 14 days to…

Calcium PhosphatesMaterials scienceCompressive StrengthCell SurvivalBiomedical EngineeringBioengineeringBone remodelingCell LineBiomaterialschemistry.chemical_compoundIn vivoBiomimetic MaterialsHardnessElastic ModulusMaterials TestingmedicineHumansViability assayCytotoxicityChitosanOsteoblastsOsteoblastIn vitroVascular endothelial growth factormedicine.anatomical_structurechemistryCell cultureBone SubstitutesBiophysicsBiomedical engineeringBiomedical materials (Bristol, England)
researchProduct

Influence of β-tricalcium phosphate granule size and morphology on tissue reaction in vivo.

2010

In this study the tissue reaction to five different β-tricalcium phosphate (β-TCP)-based bone substitute materials differing only in size, shape and porosity was analyzed over 60 days, at 3, 10, 15, 30 and 60 days after implantation. Using the subcutaneous implantation model in Wistar rats both the inflammatory response within the implantation bed and the resulting vascularization of the biomaterials were qualitatively and quantitatively assessed by means of standard and special histological staining methods. The data from this study showed that all investigated β-TCP bone substitutes induced the formation of multinucleated giant cells. Changes in size, shape and porosity influenced the int…

Calcium PhosphatesVascular Endothelial Growth Factor AChemokineMaterials scienceCellBiomedical EngineeringNeovascularization PhysiologicBiocompatible MaterialsBiochemistryGiant CellsBiomaterialschemistry.chemical_compoundImplants ExperimentalX-Ray DiffractionIn vivomedicineAnimalsParticle SizeRats WistarMolecular BiologybiologyGranule (cell biology)Acid phosphataseBiomaterialGeneral MedicineAnatomyImmunohistochemistryRatsVascular endothelial growth factormedicine.anatomical_structurechemistryGiant cellOrgan SpecificityBone Substitutesbiology.proteinBiophysicsMicroscopy Electron ScanningBiotechnologyActa biomaterialia
researchProduct